Swissmedic, Switzerland’s agency for the authorization and supervision of therapeutic products, has announced an extension of…
Category: Switzerland
Switzerland updates on medical device regulation and quality.
Swissmedic Announces Authorization of Ayvakyt®: A Clinical Update
Swissmedic, the Swiss agency for therapeutic products, has announced the first regulatory authorization for Ayvakyt®. This…
Swissmedic Grants Initial Authorization for Wainzua®: Key Regulatory Update
Swissmedic, the Swiss agency responsible for licensing and monitoring therapeutic products, has announced the initial authorization…
Tamsulosin and Its Association with Intraoperative Floppy Iris Syndrome: Swissmedic Insights
Swissmedic has issued an important notice about the risks of intraoperative floppy iris syndrome (IFIS) among…
Swissmedic Updates on Veterinary Drug Reactions: Key Insights from 2024 Reports
The latest vigilance report from Swissmedic highlights significant findings regarding adverse reactions to veterinary medicinal products…
Swissmedic Advisory: Reduced Shelf Life for Lecigon (Carbidopa/Entacapone/Levodopa)
Swissmedic has issued a health professional communication regarding a change in the shelf life of Lecigon,…
Swissmedic Approves Initial Authorization for Sogroya®: Key Details for Regulatory Professionals
Swissmedic has announced the first authorization for Sogroya®, marking a significant regulatory development. The approval introduces…
Swissmedic Update: Revised EU Medical Device Regulations Explained
On October 21, 2025, Swissmedic announced updates to key sections related to EU legal acts for…
Temporary Authorization Issued for Seroquel XR 50 mg Tablets in Italian Packaging
On October 20, 2025, Swissmedic announced a temporary resolution to the supply shortage of Seroquel XR…
Swissmedic Grants Initial Approval for Imcivree®: What You Need to Know
Swissmedic has officially granted the initial authorisation for Imcivree®. This significant regulatory decision is vital for…